Anil Bagri
Chief Scientific Officer @SRT Therapeutics Inc.
Signup · Get unlimited contacts
WORK HISTORY
Chief Scientific Officer @SRT Therapeutics Inc.
San Diego, CA, US
I am responsible for the strategic direction and execution of SRT Therapeutics’ scientific and development portfolio- I have built a world-class team of scientists as we navigate the high-stakes challenges of drug development to deliver first-in-class, targeted therapies for patients with significant unmet needs- I lead cross-functional efforts to translate complex IBD biology into a robust clinical pipeline, managing all aspects of R&D strategy, talent development, and organizational growth from the ground up to achieve transformative patient outcomes.
EDUCATION
University of California, San Francisco - School of Medicine
Residency - Anatomic Pathology
University of California, San Francisco - School of Medicine
PhD, Developmental Neuroscience
University of California, San Francisco - School of Medicine
Fellowship, Molecular Medicine
University of California, Berkeley
BA with Honors, Molecular Cell Biology - Genetics
University of California, San Francisco - School of Medicine
MD (MSTP)
SKILLS
ABOUT ANIL BAGRI
With over 20 years of experience as a results-driven physician-scientist, I am deeply passionate about driving groundbreaking discoveries and spearheading the pre-clinical development of antibody and next-generation therapeutics. Throughout my career, I have successfully led cross-functional teams, fostering innovation and formulating creative solutions to advance cutting-edge treatments to improve patient outcomes. Expertise and Key Skills- Therapeutic Development - Demonstrated track record of delivering multiple therapeutics to the clinic with strong scientific rigor and a deep understanding of drug development- Pipeline Strategy - A passionate leader with proven ability to develop and execute a clinically and commercially relevant research pipeline strategy, leveraging the organization\'s core competency and platform technology- Cross-Functional execution of projects - A track record of successfully directing cross-functional projects across various development stages, encompassing biologics including antibodies, gene and cell therapies- Innovative Problem-Solving - A strategic thinker who drives innovation by identifying opportunities for expansion and formulating creative, problem-driven solutions that guide the decisions of Executive Management and Board of Directors and contributing to the success of the organization- Patient-Centric Approach - Committed to collaboratively bringing life changing therapeutics to patients, drawing from a strong clinical and scientific background.Achievements & Impact Fate Therapeutics: I established and oversee a cutting-edge cellular therapeutics research organization, focusing on pioneering first- and best-in-class treatments. I lead strategic therapeutic area assessments, formulate pipeline strategy, and ensure seamless execution from cross-functional teams leading to successful filing of 1 IND in <2 yr. Cerus Corporation: Led Therapeutic pipeline strategy, securing $10M and paving the way for an additional $20M of non-dilutive funds for new initiatives leading to successful launch of 2 products. BioMarin Pharmaceutical: Held pivotal scientific and strategic leadership roles, contributed to multiple INDs, identified novel opportunities and lead all aspects of a gene therapy product from research to the clinic. Influenced critical decisions at the corporate level. Genentech: As Senior Scientist, directed productive research programs, supporting multiple new pipeline projects and marketed therapeutics in oncology.#ChiefScientificOfficer #Innovation #BiotechLeader #RDStrategist
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.